DrugMapper


Display Options: Drug type Therapeutic Area Route of administration Mechanism of Action Indication Status		Total: 1496


Protein Approved OTHER INJECTION Unknown Unknown


Small molecule Approved OTHER ORAL Unknown Unknown


Small molecule Approved OTHER ORAL Multiple Sclerosis, Chronic Progressive; Diabetes Mellitus, Type 2; Essential Hypertension; Cardiovascular Diseases; Heart Failure; Hypertension; Toxemia Thiazide-sensitive sodium-chloride cotransporter inhibitor


Small molecule Approved OTHER TOPICAL; VAGINAL Unknown Cytochrome P450 51 inhibitor


Small molecule Approved OTHER INJECTION; ORAL Fallopian Tube Neoplasms; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Plasma Cell; Lymphoma, Primary Effusion; Myelodysplastic-Myeloproliferative Diseases; Neoplasms, Neuroepithelial; Neuroendocrine Tumors; Peritoneal Neoplasms; Sarcoma, Kaposi; Acquired Immunodeficiency Syndrome; Astrocytoma; Carcinoid Tumor; Carcinoma, Hepatocellular; Carcinoma, Islet Cell; Carcinoma, Large Cell; Carcinoma, Merkel Cell; Carcinoma, Neuroendocrine; Castleman Disease; Esthesioneuroblastoma, Olfactory; Glioblastoma; Glioma; Gliosarcoma; Graft vs Host Disease; Hematologic Diseases; Hematologic Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, AIDS-Related; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell; Multiple Sclerosis, Relapsing-Remitting; Myasthenia Gravis; Neoplasms, Plasma Cell; Neuromyelitis Optica; Neutropenia; Oligodendroglioma; Opsoclonus-Myoclonus Syndrome; Optic Nerve Glioma; Oropharyngeal Neoplasms; Pancreatic Neoplasms; Paraganglioma; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Prostatic Neoplasms; Rhabdomyosarcoma, Alveolar; Rhabdomyosarcoma, Embryonal; Severe Acute Respiratory Syndrome; Stiff-Person Syndrome; Thymoma; Waldenstrom Macroglobulinemia; Adenocarcinoma of Lung; Adrenal Cortex Neoplasms; Anemia, Refractory; Anemia, Refractory, with Excess of Blasts; Brain Neoplasms; Breast Neoplasms; Burkitt Lymphoma; Carcinoma; Carcinoma, Embryonal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Central Nervous System Neoplasms; Choriocarcinoma; Choroid Plexus Neoplasms; Colorectal Neoplasms; Endodermal Sinus Tumor; Ependymoma; Ganglioneuroblastoma; Gestational Trophoblastic Disease; Granuloma, Lethal Midline; Hepatoblastoma; HIV Infections; Hodgkin Disease; Kidney Neoplasms; Leukemia; Leukemia, Basophilic, Acute; Leukemia, Biphenotypic, Acute; Leukemia, Erythroblastic, Acute; Leukemia, Lymphoid; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Megakaryoblastic, Acute; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Leukemia, Myelomonocytic, Chronic; Lymphohistiocytosis, Hemophagocytic; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Peripheral; Mediastinal Neoplasms; Medulloblastoma; Multiple Myeloma; Myelodysplastic Syndromes; Myeloproliferative Disorders; Neoplasms, Germ Cell and Embryonal; Neuroblastoma; Neuroectodermal Tumors, Primitive; Osteosarcoma; Ovarian Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prostatic Neoplasms, Castration-Resistant; Retinoblastoma; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Sarcoma, Myeloid; Seminoma; Sex Cord-Gonadal Stromal Tumors; Stomach Neoplasms; Teratoma; Testicular Neoplasms; Thymus Neoplasms; Wilms Tumor; Carcinoma, Small Cell; Lung Neoplasms; Neoplasms; Small Cell Lung Carcinoma DNA topoisomerase II inhibitor

Small molecule

Approved

OTHER

INJECTION; ORAL

Fallopian Tube Neoplasms; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Plasma Cell; Lymphoma, Primary Effusion; Myelodysplastic-Myeloproliferative Diseases; Neoplasms, Neuroepithelial; Neuroendocrine Tumors; Peritoneal Neoplasms; Sarcoma, Kaposi; Acquired Immunodeficiency Syndrome; Astrocytoma; Carcinoid Tumor; Carcinoma, Hepatocellular; Carcinoma, Islet Cell; Carcinoma, Large Cell; Carcinoma, Merkel Cell; Carcinoma, Neuroendocrine; Castleman Disease; Esthesioneuroblastoma, Olfactory; Glioblastoma; Glioma; Gliosarcoma; Graft vs Host Disease; Hematologic Diseases; Hematologic Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, AIDS-Related; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell; Multiple Sclerosis, Relapsing-Remitting; Myasthenia Gravis; Neoplasms, Plasma Cell; Neuromyelitis Optica; Neutropenia; Oligodendroglioma; Opsoclonus-Myoclonus Syndrome; Optic Nerve Glioma; Oropharyngeal Neoplasms; Pancreatic Neoplasms; Paraganglioma; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Prostatic Neoplasms; Rhabdomyosarcoma, Alveolar; Rhabdomyosarcoma, Embryonal; Severe Acute Respiratory Syndrome; Stiff-Person Syndrome; Thymoma; Waldenstrom Macroglobulinemia; Adenocarcinoma of Lung; Adrenal Cortex Neoplasms; Anemia, Refractory; Anemia, Refractory, with Excess of Blasts; Brain Neoplasms; Breast Neoplasms; Burkitt Lymphoma; Carcinoma; Carcinoma, Embryonal; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Central Nervous System Neoplasms; Choriocarcinoma; Choroid Plexus Neoplasms; Colorectal Neoplasms; Endodermal Sinus Tumor; Ependymoma; Ganglioneuroblastoma; Gestational Trophoblastic Disease; Granuloma, Lethal Midline; Hepatoblastoma; HIV Infections; Hodgkin Disease; Kidney Neoplasms; Leukemia; Leukemia, Basophilic, Acute; Leukemia, Biphenotypic, Acute; Leukemia, Erythroblastic, Acute; Leukemia, Lymphoid; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Megakaryoblastic, Acute; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Leukemia, Myelomonocytic, Chronic; Lymphohistiocytosis, Hemophagocytic; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Peripheral; Mediastinal Neoplasms; Medulloblastoma; Multiple Myeloma; Myelodysplastic Syndromes; Myeloproliferative Disorders; Neoplasms, Germ Cell and Embryonal; Neuroblastoma; Neuroectodermal Tumors, Primitive; Osteosarcoma; Ovarian Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prostatic Neoplasms, Castration-Resistant; Retinoblastoma; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Sarcoma, Myeloid; Seminoma; Sex Cord-Gonadal Stromal Tumors; Stomach Neoplasms; Teratoma; Testicular Neoplasms; Thymus Neoplasms; Wilms Tumor; Carcinoma, Small Cell; Lung Neoplasms; Neoplasms; Small Cell Lung Carcinoma

DNA topoisomerase II inhibitor


Small molecule Approved OTHER ORAL Irritable Bowel Syndrome; Paraplegia; Metabolism, Inborn Errors; Xanthomatosis, Cerebrotendinous Bile acid receptor FXR agonist


Small molecule Approved OTHER INJECTION Endophthalmitis; Osteomyelitis; Appendicitis; Pneumonia; Bacterial Infections; Eye Infections Unknown


Small molecule Approved OTHER INJECTION; ORAL Carcinoma, Hepatocellular; Diabetes Mellitus, Type 2; Seizures; Alzheimer Disease; Down Syndrome; Hypokalemic Periodic Paralysis; Renal Insufficiency, Chronic; Autistic Disorder; Child Development Disorders, Pervasive; Cardiovascular Diseases; Heart Failure; Kidney Diseases; Nephrotic Syndrome Sodium-(potassium)-chloride cotransporter 2 inhibitor


Small molecule Approved OTHER INHALATION Unknown Beta-2 adrenergic receptor agonist


Small molecule Approved OTHER INHALATION Unknown Beta-2 adrenergic receptor agonist


Small molecule Approved OTHER INJECTION Unknown Phosphodiesterase 3A inhibitor


Small molecule Approved OTHER ORAL Peripheral Nerve Injuries; Clostridium Infections; Crohn Disease; Colonic Neoplasms; Colorectal Neoplasms; Diabetes Mellitus; Hepatitis C; Hepatitis C, Chronic; Constipation Osmotic laxative


Small molecule Approved OTHER ORAL Amyotrophic Lateral Sclerosis; Anxiety; Dementia; Depressive Disorder; Schizophrenia; Psychotic Disorders; Tics; Tourette Syndrome Dopamine receptor antagonist


Small molecule Approved DIABETES DRUGS & ENDOCRINOLOGY; OTHER ORAL Pancreatic Neoplasms; Atherosclerosis; Renal Insufficiency, Chronic; Diabetes Mellitus; Diabetes Mellitus, Type 2 Sulfonylurea receptor 1, Kir6.2 blocker


Small molecule Approved DIABETES DRUGS & ENDOCRINOLOGY; HEMATOLOGY; OTHER ORAL Angina, Stable; Ischemic Stroke; Spinal Cord Injuries; Brain Injuries; Diabetes Mellitus, Type 1; Stroke; Diabetes, Gestational; Diabetes Mellitus; Diabetes Mellitus, Type 2 Sulfonylurea receptor 1, Kir6.2 blocker


Unknown Approved OTHER INJECTION Unknown Unknown


Small molecule Approved OTHER ORAL Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Adrenal Gland Diseases 3-beta-hydroxysteroid dehydrogenase/delta 5-->4-isomerase type II inhibitor


Small molecule Approved OTHER INJECTION Bacterial Infections Bacterial penicillin-binding protein inhibitor


Small molecule Approved OTHER INJECTION Bacterial Infections Bacterial penicillin-binding protein 2 inhibitor


Small molecule Approved OTHER NASAL; ORAL; TRANSDERMAL Aging; Attention Deficit Disorder with Hyperactivity; Cocaine-Related Disorders; Memory Disorders; Sarcoidosis; Sarcoidosis, Pulmonary; Schizophrenia; Substance-Related Disorders; Alcohol Drinking; Carcinoma; Cognitive Dysfunction; Depressive Disorder; Parkinson Disease; Postoperative Nausea and Vomiting; Sarcoma; Wounds and Injuries; Heart Failure; Lung Neoplasms; Marijuana Abuse; Pulmonary Disease, Chronic Obstructive; Severe Acute Respiratory Syndrome; Smoking; Smoking Cessation; Uterine Cervical Neoplasms; Tobacco Use Disorder Neuronal acetylcholine receptor; alpha4/beta2 agonist

Small molecule

Approved

OTHER

NASAL; ORAL; TRANSDERMAL

Aging; Attention Deficit Disorder with Hyperactivity; Cocaine-Related Disorders; Memory Disorders; Sarcoidosis; Sarcoidosis, Pulmonary; Schizophrenia; Substance-Related Disorders; Alcohol Drinking; Carcinoma; Cognitive Dysfunction; Depressive Disorder; Parkinson Disease; Postoperative Nausea and Vomiting; Sarcoma; Wounds and Injuries; Heart Failure; Lung Neoplasms; Marijuana Abuse; Pulmonary Disease, Chronic Obstructive; Severe Acute Respiratory Syndrome; Smoking; Smoking Cessation; Uterine Cervical Neoplasms; Tobacco Use Disorder

Neuronal acetylcholine receptor; alpha4/beta2 agonist


Small molecule Approved CARDIOVASCULAR; OTHER ORAL Alopecia Areata; Anemia; Bipolar Disorder; Central Nervous System Neoplasms; Cognitive Dysfunction; Crohn Disease; Hermanski-Pudlak Syndrome; HIV Infections; Infertility; Muscular Dystrophy, Duchenne; Oral Submucous Fibrosis; Pancreatitis; Schizophrenia; Severe Acute Respiratory Syndrome; Acute Coronary Syndrome; Acute Kidney Injury; Behcet Syndrome; Biliary Atresia; Brain Diseases; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Coronary Disease; Depressive Disorder; Depressive Disorder, Major; Diabetic Nephropathies; Ductus Arteriosus, Patent; Epilepsy; Fatty Liver; Fibrosis; Head and Neck Neoplasms; Heart Diseases; Inflammatory Bowel Diseases; Leishmaniasis; Leishmaniasis, Cutaneous; Liver Cirrhosis, Biliary; Liver Diseases; Malaria, Falciparum; Neoplasms; Non-alcoholic Fatty Liver Disease; Parkinson Disease; Post-Acute COVID-19 Syndrome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sarcoidosis, Pulmonary; Sexually Transmitted Diseases; Wounds and Injuries; Brachial Plexus Neuropathies; Endometriosis; Enterocolitis, Necrotizing; Glomerulonephritis; Hepatitis, Alcoholic; Jaundice; Kidney Failure, Chronic; Liver Cirrhosis; Liver Failure; Neonatal Sepsis; Nephrotic Syndrome; Osteonecrosis; Renal Insufficiency, Chronic; Cardiovascular Diseases 3',5'-cyclic phosphodiesterase inhibitor

Small molecule

Approved

CARDIOVASCULAR; OTHER

ORAL

Alopecia Areata; Anemia; Bipolar Disorder; Central Nervous System Neoplasms; Cognitive Dysfunction; Crohn Disease; Hermanski-Pudlak Syndrome; HIV Infections; Infertility; Muscular Dystrophy, Duchenne; Oral Submucous Fibrosis; Pancreatitis; Schizophrenia; Severe Acute Respiratory Syndrome; Acute Coronary Syndrome; Acute Kidney Injury; Behcet Syndrome; Biliary Atresia; Brain Diseases; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Coronary Disease; Depressive Disorder; Depressive Disorder, Major; Diabetic Nephropathies; Ductus Arteriosus, Patent; Epilepsy; Fatty Liver; Fibrosis; Head and Neck Neoplasms; Heart Diseases; Inflammatory Bowel Diseases; Leishmaniasis; Leishmaniasis, Cutaneous; Liver Cirrhosis, Biliary; Liver Diseases; Malaria, Falciparum; Neoplasms; Non-alcoholic Fatty Liver Disease; Parkinson Disease; Post-Acute COVID-19 Syndrome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sarcoidosis, Pulmonary; Sexually Transmitted Diseases; Wounds and Injuries; Brachial Plexus Neuropathies; Endometriosis; Enterocolitis, Necrotizing; Glomerulonephritis; Hepatitis, Alcoholic; Jaundice; Kidney Failure, Chronic; Liver Cirrhosis; Liver Failure; Neonatal Sepsis; Nephrotic Syndrome; Osteonecrosis; Renal Insufficiency, Chronic; Cardiovascular Diseases

3',5'-cyclic phosphodiesterase inhibitor


Small molecule Approved OTHER TOPICAL Unknown Unknown


Small molecule Approved OTHER INJECTION; ORAL; RECTAL; URETHRAL Breast Neoplasms; Fabry Disease; HIV Infections; Neoplasms; Renal Insufficiency; Acute Kidney Injury; Kidney Diseases; Myocardial Ischemia Diagnostic agent


Small molecule Approved OTHER INJECTION Breast Neoplasms; Carcinoma, Renal Cell; Prostatic Neoplasms, Castration-Resistant; Urinary Bladder Neoplasms; Glioma; Pituitary Neoplasms Diagnostic agent


Protein Approved OTHER INJECTION Diabetes Mellitus Insulin receptor agonist


Protein Approved OTHER INJECTION Hyperglycemia; Atherosclerosis; Coronary Disease; Diabetes Mellitus, Type 2; Hypercholesterolemia; Hypertension Insulin receptor agonist


Small molecule Approved OTHER OPHTHALMIC Rheumatic Diseases Cyclooxygenase inhibitor


Small molecule Approved OTHER BILIARY; PERFUSION Unknown Unknown


Small molecule Approved OTHER TOPICAL Tinea Pedis Cytochrome P450 51 inhibitor

Small molecule

Approved

GASTROINTESTINAL; IMMUNE SYSTEM; OTHER

INHALATION; ORAL

Breast Neoplasms; Neoplasms; Diabetes Mellitus, Type 1; Encephalitis, Japanese; Hemorrhagic Fever with Renal Syndrome; Hepatitis D; Influenza, Human; Lassa Fever; Leukemia, Myeloid, Acute; Thrombocytopenia; Depressive Disorder; Hepatitis; Hepatitis B, Chronic; Hepatitis C; HIV Infections; Infections; Respiratory Syncytial Virus Infections; Severe Acute Respiratory Syndrome; Fibrosis; Hepatitis C, Chronic; Liver Cirrhosis; Virus Diseases

Inosine-5'-monophosphate dehydrogenase 1 inhibitor


Small molecule Approved OTHER ORAL Adenocarcinoma of Lung; Amebiasis; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Glioblastoma; HIV Infections; Small Cell Lung Carcinoma; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Ovarian Neoplasms; Pain; Tuberculosis; Arthritis, Rheumatoid; Rheumatic Diseases Unknown


Protein Approved OTHER INJECTION Unknown Growth hormone receptor agonist


Small molecule Approved OTHER ORAL Sleep Initiation and Maintenance Disorders GABA-A receptor; anion channel positive allosteric modulator


Small molecule Approved OTHER ORAL Obsessive-Compulsive Disorder; Fibromyalgia; Marijuana Abuse; Muscle Spasticity; Neuralgia; Obesity; Suicidal Ideation; Diabetic Neuropathies; Parkinson Disease; Nausea; Neoplasms; Postoperative Nausea and Vomiting Cannabinoid CB1 receptor agonist


Small molecule Approved OTHER INJECTION Cystic Fibrosis; Osteomyelitis; Esophageal Achalasia; Meningitis, Bacterial; Enterobacteriaceae Infections; Skin Diseases; Staphylococcal Skin Infections; Bacterial Infections; Infections; Intraabdominal Infections; Parametritis; Peritonitis; Pneumonia; Pyelonephritis; Urinary Tract Infections Bacterial penicillin-binding protein inhibitor